Beauty Health Company (The) - Warrants (04/05/2026) Profit Margin

Beauty Health Company (The) - Warrants (04/05/2026) posts a profit margin of -6.33% as of September 2026. That compares with -3.89% in the prior-year period — down 62.8% year over year. That is below the Healthcare sector average of 19.13%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Beauty Health Company (The) - Warrants (04/05/2026)'s profit margin was -3.89%. The latest reading is -6.33% — a 62.8% year-over-year decrease (period ending September 2026). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a profit margin near 19.13% is typical. Beauty Health Company (The) - Warrants (04/05/2026)'s -6.33% is lower that level. That is roughly 133.1% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Beauty Health Company (The) - Warrants (04/05/2026)'s profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is -6.33% as of September 2026; use YoY and peer views to separate noise from signal.

Context for SKINW's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 19.13%), and (3) consistency with growth and profitability. This page covers the first two; Beauty Health Company (The) - Warrants (04/05/2026)'s other metric pages and overview cover the third.